![Paul Y. Song](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Y. Song
Vorstandsvorsitzender bei NKGen Biotech, Inc.
Vermögen: 284 409 $ am 31.05.2024
Aktive Positionen von Paul Y. Song
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NKGen Biotech, Inc.
![]() NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Vorsitzender | - | - |
Vorstandsvorsitzender | 10.01.2023 | - | |
Direktor/Vorstandsmitglied | - | - | |
Technik-/Wissenschafts-/F&E-Leiter | - | 10.01.2023 | |
PeproMene Bio, Inc.
![]() PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Direktor/Vorstandsmitglied | 01.03.2022 | - |
Mercy Corps
![]() Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Direktor/Vorstandsmitglied | - | - |
Gideons Promise, Inc. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Paul Y. Song
Ehemalige bekannte Positionen von Paul Y. Song
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Fuse Biotherapeutics, Inc.
![]() Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Direktor/Vorstandsmitglied | 01.06.2021 | 01.01.2023 |
Vorstandsvorsitzender | 01.06.2021 | 01.01.2023 | |
Gründer | 01.06.2021 | 01.01.2023 | |
NKMAX CO., LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2016 | 01.01.2021 |
Ausbildung von Paul Y. Song
George Washington University School of Medicine & Health | Doctorate Degree |
The University of Chicago | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Südkorea | 2 |
Operativ
Director/Board Member | 6 |
Chief Executive Officer | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NKMAX CO., LTD. | Health Technology |
Private Unternehmen | 5 |
---|---|
NKGen Biotech, Inc.
![]() NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
Fuse Biotherapeutics, Inc.
![]() Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Health Technology |
PeproMene Bio, Inc.
![]() PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Health Technology |
Mercy Corps
![]() Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Health Services |
Gideons Promise, Inc. |
- Börse
- Insiders
- Paul Y. Song
- Erfahrung